How orvos helps providers

Diabetic retinopathy remains one of the most preventable causes of blindness. Whether in an endocrinology clinic, a primary care office, or a home health visit, providers can leverage Orvos to bring retina screening to the point of care. This ensures patients receive complete, proactive diabetes management without unnecessary delays. 

Every provider faces pressure to meet HEDIS, NCQA, and value-based care metrics. Orvos makes diabetic eye exam compliance seamless with fast, documented, and billable screenings. This improves quality scores, reduces audit risk, and drives higher reimbursement across all care models. 

 By enabling retina screenings across multiple points of care, Orvos supports population health management and strengthens performance in value-based care contracts. Providers reduce complications, prevent costly blindness, and improve shared savings outcomes. 

•  At-home access: Many diabetic patients face barriers to traveling for specialty care. Orvos enables home health providers to bring screenings directly to patients.
   
• Reducing readmissions: Preventive eye screenings help avoid complications that could lead to emergency visits or costly interventions.
   
• Revenue capture: Home health agencies can bill for screenings performed in the home, expanding service offerings and financial sustainability.

 Preventive care is not just good medicine — it’s good business. Clinics that implement Orvos’ retina screening solutions see an immediate return on investment through reimbursement, higher quality scores, and improved patient retention. By preventing costly complications like blindness, practices also reduce the long-term burden of unmanaged diabetes.